Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Medzoomer
AddedFeb 15, 2024
UpdatedJul 4, 2026
Medzoomer

Medzoomer

Series A

MedZoomer: Your on-demand platform for doorstep prescription delivery.

HQ
Middletown, DE, US
Founded
2019
Accelerator
Techstars logoTechstars: UnitedHealthcare2021
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize medication access, MedZoomer is an on-demand prescription delivery platform that ensures medications are delivered from pharmacies directly to patients' doorsteps. The company aims to provide a seamless, secure, and convenient service for patients, allowing them to receive their prescriptions without leaving their homes. MedZoomer partners with pharmacies to facilitate this process, ensuring that all deliveries are handled by HIPAA-certified couriers to maintain patient confidentiality and safety.

MedZoomer has garnered attention for its innovative approach to healthcare logistics, attracting notable investors and industry experts. The platform has achieved significant milestones, including expanding its network of pharmacy partners and enhancing its delivery infrastructure to cover a broader geographic area. By addressing a critical need in the healthcare system, MedZoomer has made a substantial impact on improving medication adherence and patient convenience, setting a new standard for prescription delivery services.

Medzoomer - Similar Companies

NimbleRx logo

NimbleRx

nimblerx.com

Pills2Me logo

Pills2Me

pills2me.com

Rx Delivered Now logo

Rx Delivered Now

rxdeliverednow.com

ScriptDrop logo

ScriptDrop

scriptdrop.co

Health Haven Rx logo

Health Haven Rx

healthhavenrx.com

RobinHealth logo

RobinHealth

Gifthealth logo

Gifthealth

gifthealth.com

DiRx logo

DiRx

dirxhealth.com

DeliverCareRx logo

DeliverCareRx

delivercarerx.com

Medsbyme logo

Medsbyme

ScriptAssist Pharmacy logo

ScriptAssist Pharmacy

scriptassistrx.com

Truepill logo

Truepill

mymedscom logo

mymedscom

mymedscom.com

MedMe Health logo

MedMe Health

medmehealth.com

Mednow.ca logo

Mednow.ca

mednow.ca

Medzoomer - Quick Facts

Who are Medzoomer's competitors?

Companies similar to Medzoomer include NimbleRx, Pills2Me, Rx Delivered Now and ScriptDrop.

When was Medzoomer founded?

Medzoomer was founded in 2019.

Where is Medzoomer's headquarters located?

Medzoomer's headquarters is located in Middletown, DE, US.

How much has Medzoomer raised to-date?

As of Aug 24, 2023, Medzoomer has raised a total of $3.4M (USD).

How many employees does Medzoomer have?

Medzoomer has 24 employees as of Feb 5, 2024.

Medzoomer - Classification

Technology
  • Logistics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • SaaS
  • Transactional
Customer
  • Consumers
Main Product
  • Prescription Delivery
Tags
  • API
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 5900Miscellaneous Retail
  • 5910Drug Stores And Proprietary Stores